Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to assess the effects of varying degrees of renal dysfunction and hepatic insufficiency
on the single-dose pharmacokinetics of nevirapine and nevirapine metabolites in order to
establish an appropriate dose and/or dosing frequency for renally- and hepatically-impaired
patients